Skip to content
ClosedNo longer accepting applications

AD/ADRD Clinical Trials Short Course

National Institutes of Health

About this archived opportunity

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to expand the skilled Alzheimer's disease (AD) and AD-related dementias (ADRD) clinical trial workforce by developing creative and innovative short courses to train the next generation of AD/ADRD clinical trialists in state-of-the-art clinical research skills. This field covers AD, frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and mixed dementia, and the development of interventions to treat and prevent dementia, provide dementia care, and promote the health and well-being of dementia caregivers. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO intends to utilize the R25 activity code. Investigators with expertise and insights into this area of aging research are encouraged to begin to consider applying for this new NOFO.

Historical details

Status
Closed
Deadline
January 25, 2026
First captured
October 23, 2025
Publisher reference
359856

This opportunity has closed

AD/ADRD Clinical Trials Short Course

by National Institutes of Health

Get notified when similar opportunities open

We'll save this search and email you when new clinical, trials, short opportunities are posted. Free.

Refine this search